Clinical Trial Update: Phentermine/Topiramate for Uric Acid Stones [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the obesity drug combination phentermine/topiramate for uric acid nephrolithiasis has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Pre-diabetes
• Type 2 Diabetes Mellitus
• Uric Acid Nephrolithiasis

Drugs mentioned

• Qsymia (phentermine/topiramate)

Snippet

Sponsor: University of Florida | Conditions: Obesity, Uric Acid Stones | Phase 3 | Status: COMPLETED | Results posted: 2026-01-30